Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-26

Clinical Trial Update: Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of adding alogliptin to metformin in adults with Type 2 diabetes; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nesina (alogliptin)
  • metformin (metformin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2013-03-26